Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program. Pattipaka T, Sarp S, Nakhaei P, Gunes S, et al. Bone Marrow Transplant 2024 Feb 15. doi: 10.1038/s41409-024-02207.

Read + Share

Amedeo Smart

Independent Medical Education

Pattipaka T, Sarp S, Nakhaei P, Gunes S, et al. Ruxolitinib in patients with graft versus host disease (GvHD): findings from a compassionate use program. Bone Marrow Transplant 2024 Feb 15. doi: 10.1038/s41409-024-02207.
PMID: 38361117